Stay updated on Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedEdited the PubMed publication note to 'automatically filled in from PubMed' and added related topics 'Multiple myeloma' and 'MedlinePlus Genetics', with revision updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding and operating status notice from the page. No substantive study details were altered.SummaryDifference0.2%

- Check35 days agoChange DetectedLocation updated to 'Tainan, Taiwan' (replacing 'Tainan City, Taiwan'). The study description now removes the disease 'Multiple myeloma' and the related topic 'MedlinePlus Genetics'.SummaryDifference0.1%

- Check49 days agoChange DetectedMinor UI tweaks and updated timestamps observed; core study details, eligibility criteria, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedAdded MedlinePlus Genetics topic on multiple myeloma to the page.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma. Overall, a genetics-related content item was deleted.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial page.